What's new

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 9, Status: Authorised

Feb 25, 2025 - 13:23
 0
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Tech Tools and Tactics That Empower Hotel General Managers

Next Article

Human medicines European public assessment report (EPAR): Pregabalin Pfizer, pre...

Related Posts

Substance and product data management services

Substance and product data management services

Feb 14, 2025  0

Clinical Trial Information System (CTIS) evaluation tim...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 7, 2025  0